Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Catalyst Pharmaceuticals, Inc.
Type
Public company
Traded as NASDAQ: CPRX
Industry Biotechnology
Headquarters Coral Gables, FL, USA
Key people
Patrick J. McEnany, Co-Founder, Chairman, President and Chief Executive Officer
Products in development
Revenue US$ 0 million (2014)
Operating income
Decrease US$ -15.5 million (2014)
Total assets Increase US$ 43.9 million (2014)
Total equity Increase US$ 35.2 million (2014)
Number of employees
20 as of March 20, 2015
Website www.catalystpharma.com
Footnotes / references

Catalyst Pharmaceuticals is a biopharmaceutical company based in Coral Gables, Florida. The company is developing therapeutics for rare neurological diseases, including Firdapse (3,4-diaminopyridine phosphate, a potassium channel blocker) for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) and CPP-115 (a GABA transaminase) for the treatment of infantile spasms.

Investment goal date:
Dividends reinvested
Catalyst Pharmaceuticals, Inc. CPRX report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-03-16
--
--
Q3 2017
2017-11-07
--
--
Q2 2017
2017-08-09
-0.0500
-0.0500
Q1 2017
2017-05-10
-0.0600
-0.0600
Q4 2016
2017-03-15
-0.0500
-0.0500
Q3 2016
2016-11-09
-0.0500
-0.0500
Q2 2016
2016-08-09
-0.0600
-0.0600
Q1 2016
2016-05-10
-0.0700
-0.0700
Q4 2015
2016-03-15
-0.0700
-0.0700
Q3 2015
2015-11-09
-0.0500
-0.0500
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BAKER BROS. ADVISORS LP
5102153
Berson & Corrado Investment Advisors, LLC
251025
BlackRock Inc.
552803
BlackRock Institutional Trust Company, N.A.
469440
Broadfin Capital, LLC
8200000
GEODE CAPITAL MANAGEMENT, LLC
462677
HAP Trading, LLC
315000
KENNEDY CAPITAL MANAGEMENT, INC.
230500
KNOTT DAVID M
284350
Point72 Asset Management, L.P.
877266
RENAISSANCE TECHNOLOGIES LLC
382400
ROYAL BANK OF CANADA
165000
TANAKA CAPITAL MANAGEMENT INC
241753
Vanguard Group, Inc
3007935
venBio Select Advisor LLC
3804745
Major Shareholders
Name Relationship
Total Shares
Holding stocks
MCENANY PATRICK J
6.6600% (4471026)
CPRX / KOOL /
BIOMARIN PHARMACEUTICAL INC
9.9300% (6666667)
CPRX / LJPC /
COELHO PHILIP H
0.2400% (159987)
AMPE / CPRX / KOOL /
MUTH DAVID D
0.0700% (44700)
CPRX /
HUCKEL HUBERT E MD
1.9700% (1324170)
CPRX / KOOL /
WALLACE MILTON J
0.8000% (539184)
CPRX /
DENKHAUS DONALD A
0.1500% (100000)
CPRX /
Tierney David S
0.4100% (273401)
CPRX /
O'Keeffe Charles B
0.6900% (463376)
CPRX /
Winship M Douglas
0.2000% (134131)
CPRX /
Weinstein Jack
0.0200% (14493)
CPRX /
Miller Steve
0.6800% (457687)
CPRX /
% ()